Skip to main content

Table 4 Mortality according to glycemic variability (SD and CV) in patients with and without previous diabetes mellitus

From: Association between inpatient glycemic variability and COVID-19 mortality: a prospective study

 

SD < 44.7 mg/dL

SD ≥ 44.7 mg/dL

p values

 

Without DM

With DM

Without DM

With DM

 
 

n = 266

n = 52

n = 156

n = 154

 

Mortality (n = 131)

41 (13.5%)

4 (7.5%)

41 (34.7%)

45 (29.4%)

< 0.001

Mortality*

  

38 (33%)

43 (29.3%)

0.59

 

CV < 27.5%

CV ≥ 27.5%

 
 

Without DM

With DM

Without DM

With DM

 
 

n = 304

n = 53

n = 118

n = 153

 

Mortality (n = 131)

35 (13.2%)

4 (7.7%)

47 (30.1%)

45 (29.2%)

< 0.001

Mortality*

  

43 (28.3%)

43 (29.5%)

0.9

  1. Data are expressed as n (%).SD: standard deviation; CV: coefficient of variation. diabetes mellitus (DM)
  2. The comparison was made between the groups SD < 44.7 mg/dL and SD ≥ 44.7 mg/dL and CV < 27.5% and CV ≥ 27.5%. These groups were divided into patients with and without DM, to better illustrate the outcome
  3. *Mortality = mortality in patients with SD ≥ 44.7 mg/dL or CV ≥ 27.5% in whom dexamethasone was administered during hospitalization
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us